Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central Regions

Publisher： John Wiley & Sons Inc

E-ISSN： 1613-6829|11|31|3755-3761

ISSN： 1613-6810

Source： SMALL, Vol.11, Iss.31, 2015-08, pp. : 3755-3761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nationwide Japanese survey shows the characteristic features of combined central and peripheral demyelination

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 3, 2015-08 ,pp. : 214-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accumulating knowledge of the barrier system in the central and peripheral nervous system: What's next?

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 109-110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combinatorial Chemistry on Solid Support in the Search for Central Nervous System Agents

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 12, Iss. 7, 2009-08 ,pp. : 723-739

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomedical engineering: shaping future nanomedicines

By  

WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY (ELECTRONIC), Vol. 7, Iss. 2, 2015-03 ,pp. : 169-188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents

By  

NMR IN BIOMEDICINE (ELECTRONIC), Vol. 24, Iss. 10, 2011-12 ,pp. : 1380-1391

John Wiley & Sons Inc

Access to resources Recommend Favorite